Copenhagen, Denmark

Sameer Kulkarni

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Societe Des Produits Nestle S.a.. Active years: 2026.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sameer Kulkarni: Innovator in Dietary Butyrate Research

Introduction

Sameer Kulkarni is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of dietary supplements, particularly focusing on the prevention and treatment of non-alcoholic fatty liver disease. His innovative approach has led to the development of a unique compound that enhances organoleptic properties.

Latest Patents

Sameer Kulkarni holds a patent for "Dietary butyrate and its uses." This patent involves the use of a compound with specific formulas for providing a source of butyrate that has improved organoleptic properties. The compound is designed to aid in the prevention and/or treatment of non-alcoholic fatty liver disease, utilizing long-chain fatty acids with carbon chains ranging from 16 to 20.

Career Highlights

Kulkarni is currently employed at Société des Produits Nestlé S.A., where he continues to innovate in the field of dietary research. His work is pivotal in developing products that can improve health outcomes for individuals suffering from liver-related conditions.

Collaborations

Throughout his career, Sameer has collaborated with esteemed colleagues such as Amaury Patin and Elizabeth Forbes-Blom. These partnerships have fostered a collaborative environment that enhances the research and development of dietary solutions.

Conclusion

Sameer Kulkarni's contributions to dietary butyrate research exemplify his commitment to improving health through innovation. His patent and ongoing work at Société des Produits Nestlé S.A. highlight the importance of scientific advancements in addressing health challenges.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…